{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T07:26:23Z","timestamp":1774682783051,"version":"3.50.1"},"reference-count":71,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgpath.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Pathology Clinics"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.path.2023.01.011","type":"journal-article","created":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T07:49:26Z","timestamp":1680508166000},"page":"267-285","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Current Concepts in Nodal Peripheral T-Cell Lymphomas"],"prefix":"10.1016","volume":"16","author":[{"given":"Naoki","family":"Oishi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew L.","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.path.2023.01.011_bib1","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the world health organization classification of haematolymphoid tumours: lymphoid neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"issue":"11","key":"10.1016\/j.path.2023.01.011_bib2","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1182\/blood.2022015851","article-title":"The international consensus classification of mature lymphoid neoplasms: a report from the clinical advisory Committee","volume":"140","author":"Campo","year":"2022","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.path.2023.01.011_bib3","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/PAP.0000000000000047","article-title":"Anaplastic large cell lymphomas: ALK positive, ALK negative, and primary cutaneous","volume":"22","author":"Xing","year":"2015","journal-title":"Adv Anat Pathol"},{"issue":"3","key":"10.1016\/j.path.2023.01.011_bib4","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3960\/jslrt.17023","article-title":"Anaplastic large cell lymphoma: pathology, genetics, and clinical aspects","volume":"57","author":"Tsuyama","year":"2017","journal-title":"J\u00a0Clin Exp Hematop"},{"issue":"1","key":"10.1016\/j.path.2023.01.011_bib5","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/PAS.0000000000000500","article-title":"Morphologic Features of ALK-negative Anaplastic Large Cell Lymphomas With DUSP22 Rearrangements","volume":"40","author":"King","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2023.01.011_bib6","first-page":"1","article-title":"Immunohistochemical Approach to Genetic Subtyping of Anaplastic Large Cell Lymphoma","author":"Feldman","year":"2022","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.path.2023.01.011_bib7","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1097\/PAS.0000000000001614","article-title":"Striking association of lymphoid enhancing factor (LEF1) overexpression and DUSP22 rearrangements in anaplastic large cell lymphoma","volume":"45","author":"Ravindran","year":"2021","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"10.1016\/j.path.2023.01.011_bib8","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1182\/blood-2014-04-571091","article-title":"ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes","volume":"124","author":"Parilla Castellar","year":"2014","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.path.2023.01.011_bib9","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrc2291","article-title":"The anaplastic lymphoma kinase in the pathogenesis of cancer","volume":"8","author":"Chiarle","year":"2008","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"10.1016\/j.path.2023.01.011_bib10","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.3324\/haematol.2019.238766","article-title":"Whole Exome Sequencing reveals NOTCH1 mutations in anaplastic large cell lymphoma and points to Notch both as a key pathway and a potential therapeutic target","volume":"106","author":"Larose","year":"2020","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.path.2023.01.011_bib11","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1182\/blood-2010-08-303305","article-title":"Discovery of recurrent t(6;7)(p25.3;q32.3) translocations in ALK-negative anaplastic large cell lymphomas by massively parallel genomic sequencing","volume":"117","author":"Feldman","year":"2011","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.path.2023.01.011_bib12","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1182\/blood-2017-12-821868","article-title":"Genetic subtyping of breast implant\u2013associated anaplastic large cell lymphoma","volume":"132","author":"Oishi","year":"2018","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.path.2023.01.011_bib13","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1097\/PAS.0b013e318282d01e","article-title":"Chromosomal rearrangements of 6p25.3 define a new subtype of lymphomatoid papulosis","volume":"37","author":"Karai","year":"2013","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.path.2023.01.011_bib14","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/modpathol.2010.225","article-title":"Specificity of IRF4 translocations for primary cutaneous anaplastic large cell lymphoma: a multicenter study of 204 skin biopsies","volume":"24","author":"Wada","year":"2011","journal-title":"Mod Pathol"},{"issue":"6","key":"10.1016\/j.path.2023.01.011_bib15","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1111\/his.12529","article-title":"Primary cutaneous anaplastic large cell lymphomas with 6p25.3 rearrangement exhibit particular histological features","volume":"66","author":"Onaindia","year":"2015","journal-title":"Histopathology"},{"issue":"13","key":"10.1016\/j.path.2023.01.011_bib16","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1182\/blood-2018-03-838524","article-title":"Molecular profiling reveals immunogenic cues in anaplastic large cell lymphomas with DUSP22 rearrangements","volume":"132","author":"Luchtel","year":"2018","journal-title":"Blood"},{"issue":"26","key":"10.1016\/j.path.2023.01.011_bib17","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1182\/blood.2019000626","article-title":"Recurrent MSCE116K mutations in ALK-negative anaplastic large cell lymphoma","volume":"133","author":"Luchtel","year":"2019","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.path.2023.01.011_bib18","doi-asserted-by":"crossref","first-page":"e158","DOI":"10.3324\/haematol.2018.205880","article-title":"DUSP22 -rearranged anaplastic lymphomas are characterized by specific morphological features and a lack of cytotoxic and JAK\/STAT surrogate markers","volume":"104","author":"Onaindia","year":"2019","journal-title":"Haematologica"},{"issue":"11","key":"10.1016\/j.path.2023.01.011_bib19","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1182\/blood-2012-03-419937","article-title":"Genome-wide analysis reveals recurrent structural abnormalities of TP63 and other p53-related genes in peripheral T-cell lymphomas","volume":"120","author":"Vasmatzis","year":"2012","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.path.2023.01.011_bib20","doi-asserted-by":"crossref","first-page":"e253","DOI":"10.1038\/bcj.2014.73","article-title":"Somatic rearrangement of the TP63 gene preceding development of mycosis fungoides with aggressive clinical course","volume":"4","author":"Chavan","year":"2014","journal-title":"Blood Cancer J"},{"issue":"9","key":"10.1016\/j.path.2023.01.011_bib21","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1182\/blood.2019004164","article-title":"\u201cDouble-hit\u201d of DUSP22 and TP63 rearrangements in anaplastic large cell lymphoma, ALK-negative","volume":"135","author":"Karube","year":"2020","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.path.2023.01.011_bib22","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.ccell.2015.03.006","article-title":"Convergent mutations and kinase fusions lead to oncogenic STAT3 activation in anaplastic large cell lymphoma","volume":"27","author":"Crescenzo","year":"2015","journal-title":"Cancer Cell"},{"issue":"7","key":"10.1016\/j.path.2023.01.011_bib23","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1097\/PAS.0000000000001708","article-title":"JAK2 Rearrangements Are a Recurrent Alteration in CD30+ Systemic T-Cell Lymphomas With Anaplastic Morphology","volume":"45","author":"Fitzpatrick","year":"2021","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2023.01.011_bib24","article-title":"PD-L1 expression is associated with ALK positivity and STAT3 activation, but not outcome in patients with systemic anaplastic large cell lymphoma","volume":"1","author":"Shen","year":"2019","journal-title":"Mod Pathol"},{"issue":"7","key":"10.1016\/j.path.2023.01.011_bib25","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1038\/leu.2017.103","article-title":"PD-L1 is commonly expressed and transcriptionally regulated by STAT3 and MYC in ALK-negative anaplastic large-cell lymphoma","volume":"31","author":"Atsaves","year":"2017","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.path.2023.01.011_bib26","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/s41571-020-0408-9","article-title":"ROS1-dependent cancers \u2014 biology, diagnostics and therapeutics","volume":"18","author":"Drilon","year":"2021","journal-title":"Nat Rev Clin Oncol"},{"issue":"8","key":"10.1016\/j.path.2023.01.011_bib27","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1097\/PAI.0000000000000118","article-title":"Expression of the Chemokine Receptor Gene, CCR8, is Associated With DUSP22 Rearrangements in Anaplastic Large Cell Lymphoma","volume":"23","author":"Xing","year":"2015","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1016\/j.path.2023.01.011_bib28","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.humpath.2017.01.003","article-title":"Expression of p63 protein in anaplastic large cell lymphoma: implications for genetic subtyping","volume":"64","author":"Wang","year":"2017","journal-title":"Hum Pathol"},{"issue":"10","key":"10.1016\/j.path.2023.01.011_bib29","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1038\/modpathol.2013.73","article-title":"ALK-positive large B-cell lymphomas express a terminal B-cell differentiation program and activated STAT3 but lack MYC rearrangements","volume":"26","author":"Valera","year":"2013","journal-title":"Mod Pathol"},{"issue":"2","key":"10.1016\/j.path.2023.01.011_bib30","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1182\/blood.2021013338","article-title":"ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition","volume":"139","author":"Kemps","year":"2022","journal-title":"Blood"},{"issue":"33","key":"10.1016\/j.path.2023.01.011_bib31","doi-asserted-by":"crossref","first-page":"e443","DOI":"10.1200\/JCO.2012.46.7910","article-title":"Anaplastic large-cell lymphoma with aberrant expression of multiple cytokeratins masquerading as metastatic carcinoma of unknown primary","volume":"31","author":"Nguyen","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"issue":"4","key":"10.1016\/j.path.2023.01.011_bib32","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/modpathol.2010.4","article-title":"PAX5-positive T-cell anaplastic large cell lymphomas associated with extra copies of the PAX5 gene locus","volume":"23","author":"Feldman","year":"2010","journal-title":"Mod Pathol"},{"issue":"4","key":"10.1016\/j.path.2023.01.011_bib33","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1309\/PLN1NA4QB2PC1CMQ","article-title":"The expression of myeloid antigens CD13 and\/or CD33 is a marker of ALK+ anaplastic large cell lymphomas","volume":"130","author":"Bovio","year":"2008","journal-title":"Am J Clin Pathol"},{"issue":"6","key":"10.1016\/j.path.2023.01.011_bib34","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.3324\/haematol.2019.245860","article-title":"Molecular profiling reveals a hypoxia signature in breast implant-associated anaplastic large cell lymphoma","volume":"106","author":"Oishi","year":"2021","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.path.2023.01.011_bib35","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/his.14666","article-title":"CA9 expression in breast implant-associated anaplastic large cell lymphoma presenting in a lymph node","volume":"81","author":"Oishi","year":"2022","journal-title":"Histopathology"},{"issue":"4","key":"10.1016\/j.path.2023.01.011_bib36","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1182\/blood-2016-12-755496","article-title":"DUSP22 and TP63 rearrangements predict outcome of ALK-negative anaplastic large cell lymphoma: a Danish cohort study","volume":"130","author":"Pedersen","year":"2017","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.path.2023.01.011_bib37","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1111\/bjh.15860","article-title":"Identification of high-risk DUSP22-rearranged ALK-negative anaplastic large cell lymphoma","volume":"186","author":"Hapgood","year":"2019","journal-title":"Br J Haematol"},{"issue":"11","key":"10.1016\/j.path.2023.01.011_bib38","doi-asserted-by":"crossref","first-page":"4952","DOI":"10.1182\/blood-2006-10-055145","article-title":"The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells","volume":"109","author":"de Leval","year":"2007","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.path.2023.01.011_bib39","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1097\/PAS.0b013e318264e223","article-title":"TdT+ T-lymphoblastic populations are increased in castleman disease, in castleman disease in association with follicular dendritic cell tumors, and in angioimmunoblastic T-cell lymphoma","volume":"36","author":"Ohgami","year":"2012","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1016\/j.path.2023.01.011_bib40","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1097\/PAS.0b013e3181971591","article-title":"Peripheral T-cell lymphomas with a follicular growth pattern are derived from follicular helper T cells (TFH) and may show overlapping features with angioimmunoblastic T-cell lymphomas","volume":"33","author":"Huang","year":"2009","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"10.1016\/j.path.2023.01.011_bib41","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1097\/PAS.0000000000001315","article-title":"Application of a 5 marker panel to the routine diagnosis of peripheral T-cell lymphoma with T-follicular helper phenotype","volume":"43","author":"Basha","year":"2019","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.path.2023.01.011_bib42","doi-asserted-by":"crossref","first-page":"e148","DOI":"10.3324\/haematol.2016.158428","article-title":"Integrative clinicopathological and molecular analyses of angioimmunoblastic T-cell lymphoma and other nodal lymphomas of follicular helper T-cell origin","volume":"102","author":"Dobay","year":"2017","journal-title":"Haematologica"},{"issue":"9","key":"10.1016\/j.path.2023.01.011_bib43","doi-asserted-by":"crossref","first-page":"12981","DOI":"10.1111\/pin.12981","article-title":"RHOA mutation in follicular T-cell lymphoma: clinicopathological analysis of 16 cases","volume":"70","author":"Miyoshi","year":"2020","journal-title":"Pathol Int"},{"issue":"2","key":"10.1016\/j.path.2023.01.011_bib44","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/ng.2872","article-title":"Somatic RHOA mutation in angioimmunoblastic T cell lymphoma","volume":"46","author":"Sakata-Yanagimoto","year":"2014","journal-title":"Nat Genet"},{"issue":"3","key":"10.1016\/j.path.2023.01.011_bib45","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/leu.2017.273","article-title":"Activation of RHOA\u2013VAV1 signaling in angioimmunoblastic T-cell lymphoma","volume":"32","author":"Fujisawa","year":"2018","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.path.2023.01.011_bib46","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ccell.2018.01.001","article-title":"RHOA G17V induces T follicular helper cell specification and promotes lymphomagenesis","volume":"33","author":"Cortes","year":"2018","journal-title":"Cancer Cell"},{"issue":"8","key":"10.1016\/j.path.2023.01.011_bib47","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1097\/PAS.0000000000000651","article-title":"Clinicopathologic analysis of angioimmunoblastic T-cell lymphoma with or without RHOA G17V mutation Using formalin-fixed paraffin-embedded sections","volume":"40","author":"Nagao","year":"2016","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.path.2023.01.011_bib48","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/PAS.0000000000000555","article-title":"Angioimmunoblastic T-cell lymphomas With the RHOA p.Gly17Val mutation have classic clinical and pathologic features","volume":"40","author":"Ondrejka","year":"2016","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.path.2023.01.011_bib49","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/ng.2873","article-title":"Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas","volume":"46","author":"Palomero","year":"2014","journal-title":"Nat Genet"},{"issue":"6","key":"10.1016\/j.path.2023.01.011_bib50","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1038\/leu.2016.29","article-title":"DNMT3AR882H mutant and Tet2 inactivation cooperate in the deregulation of DNA methylation control to induce lymphoid malignancies in mice","volume":"30","author":"Scourzic","year":"2016","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.path.2023.01.011_bib51","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s12185-016-2122-z","article-title":"Dysregulation of TET2 in hematologic malignancies","volume":"105","author":"Chiba","year":"2017","journal-title":"Int J Hematol"},{"issue":"5","key":"10.1016\/j.path.2023.01.011_bib52","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s12185-015-1738-8","article-title":"Multistep tumorigenesis in peripheral T cell lymphoma","volume":"102","author":"Sakata-Yanagimoto","year":"2015","journal-title":"Int J Hematol"},{"issue":"10","key":"10.1016\/j.path.2023.01.011_bib53","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMc1806413","article-title":"High-risk clonal hematopoiesis as the origin of AITL and NPM1 -mutated AML","volume":"379","author":"Tiacci","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.path.2023.01.011_bib54","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/sj.leu.2404045","article-title":"Novel t(5;9)(q33;q22) fuses ITK to SYK in unspecified peripheral T-cell lymphoma","volume":"20","author":"Streubel","year":"2006","journal-title":"Leukemia"},{"issue":"9","key":"10.1016\/j.path.2023.01.011_bib55","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1097\/PAS.0b013e3182991415","article-title":"ITK\/SYK translocation in angioimmunoblastic T-cell lymphoma","volume":"37","author":"Attygalle","year":"2013","journal-title":"Am J Surg Pathol"},{"issue":"8","key":"10.1016\/j.path.2023.01.011_bib56","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1182\/blood.2019002401","article-title":"FER and FES tyrosine kinase fusions in follicular T-cell lymphoma","volume":"135","author":"Debackere","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.path.2023.01.011_bib57","doi-asserted-by":"crossref","DOI":"10.1111\/bjd.21791","article-title":"Primary cutaneous peripheral T-cell lymphomas with a T-follicular helper phenotype: an integrative clinical, pathological and molecular case series study","author":"Wang","year":"2022","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.path.2023.01.011_bib58","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1097\/PAS.0000000000001414","article-title":"Expansion of PD1-positive T cells in nodal marginal zone lymphoma","volume":"44","author":"Egan","year":"2020","journal-title":"Am J Surg Pathol"},{"issue":"12","key":"10.1016\/j.path.2023.01.011_bib59","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1182\/blood-2011-08-374371","article-title":"Retrospective analysis of prognostic factors for angioimmunoblastic T-cell lymphoma: a multicenter cooperative study in Japan","volume":"119","author":"Tokunaga","year":"2012","journal-title":"Blood"},{"issue":"19","key":"10.1016\/j.path.2023.01.011_bib60","doi-asserted-by":"crossref","first-page":"4640","DOI":"10.1182\/bloodadvances.2020002396","article-title":"T\u00a0follicular helper phenotype predicts response to histone deacetylase inhibitors in relapsed\/refractory peripheral T-cell lymphoma","volume":"4","author":"Ghione","year":"2020","journal-title":"Blood Adv"},{"issue":"2","key":"10.1016\/j.path.2023.01.011_bib61","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3960\/jslrt.20001","article-title":"Nodal EBV+ cytotoxic T-cell lymphoma: a literature review based on the 2017 WHO classification","volume":"60","author":"Kato","year":"2020","journal-title":"J\u00a0Clin Exp Hematop"},{"issue":"4","key":"10.1016\/j.path.2023.01.011_bib62","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1097\/PAS.0000000000000323","article-title":"T-cell receptor (TCR) phenotype of nodal Epstein-Barr virus (EBV)-positive cytotoxic T-cell lymphoma (CTL): a clinicopathologic study of 39 cases","volume":"39","author":"Kato","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2023.01.011_bib63","doi-asserted-by":"crossref","DOI":"10.3324\/haematol.2021.280003","article-title":"Immune pathway upregulation and lower genomic instability distinguish EBV-positive nodal T\/NK-cell lymphoma from ENKTL and PTCL-NOS","author":"Wai","year":"2022","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.path.2023.01.011_bib64","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3324\/haematol.2017.180430","article-title":"Epstein-Barr virus-associated primary nodal T\/NK-cell lymphoma shows a distinct molecular signature and copy number changes","volume":"103","author":"Ng","year":"2018","journal-title":"Haematologica"},{"issue":"16","key":"10.1016\/j.path.2023.01.011_bib65","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1200\/JCO.2005.03.6327","article-title":"Marker expression in peripheral T-cell lymphoma: a proposed clinical-pathologic prognostic score","volume":"24","author":"Went","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"issue":"19","key":"10.1016\/j.path.2023.01.011_bib66","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1182\/blood-2013-11-536359","article-title":"Gene expression signatures delineate biologic and prognostic subgroups in peripheral T-cell lymphoma","volume":"123","author":"Iqbal","year":"2014","journal-title":"Blood"},{"issue":"15","key":"10.1016\/j.path.2023.01.011_bib67","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1182\/blood-2018-09-872549","article-title":"Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma","volume":"133","author":"Heavican","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.path.2023.01.011_bib68","doi-asserted-by":"crossref","DOI":"10.1182\/blood.2021015019","article-title":"DNMT3A mutations define a unique biological and prognostic subgroup associated with cytotoxic T-cells in PTCL-NOS","author":"Herek","year":"2022","journal-title":"Blood"},{"issue":"24","key":"10.1016\/j.path.2023.01.011_bib69","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1182\/blood.2019000779","article-title":"Reproducing the molecular subclassification of peripheral T-cell lymphoma-NOS by immunohistochemistry","volume":"134","author":"Amador","year":"2019","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.path.2023.01.011_bib70","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1038\/s41375-019-0473-1","article-title":"Molecular heterogeneity in peripheral T-cell lymphoma, not otherwise specified revealed by comprehensive genetic profiling","volume":"33","author":"Watatani","year":"2019","journal-title":"Leukemia"},{"issue":"9","key":"10.1016\/j.path.2023.01.011_bib71","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1182\/blood-2016-03-707141","article-title":"Integrated mate-pair and RNA sequencing identifies novel, targetable gene fusions in peripheral T-cell lymphoma","volume":"128","author":"Boddicker","year":"2016","journal-title":"Blood"}],"container-title":["Surgical Pathology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875918123000119?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875918123000119?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T14:42:52Z","timestamp":1761748972000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1875918123000119"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":71,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S1875918123000119"],"URL":"https:\/\/doi.org\/10.1016\/j.path.2023.01.011","relation":{},"ISSN":["1875-9181"],"issn-type":[{"value":"1875-9181","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current Concepts in Nodal Peripheral T-Cell Lymphomas","name":"articletitle","label":"Article Title"},{"value":"Surgical Pathology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.path.2023.01.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}